Latest Posts - Bioscience

City of Peoria honors BioAccel

BioAccel has received the City of Peoria’s 2013 Economic Development Award for the development and management of BioInspire, a medical device-focused accelerator program. MaryAnn Guerra, BioAccel’s CEO, and Thomas Rainey, Director of BioInspire, will accept the award on behalf of BioAccel’s staff, Board and advisors at the Peoria Chamber of … [Continue Reading]

Ivy Foundation Grants Over $9M for Brain Cancer Research

The Ben & Catherine Ivy Foundation (Ivy Foundation) announced its 2012 grant recipients, which total more than $9 million in funding for brain cancer research. The Ivy Foundation is the largest privately funded brain cancer research foundation in North America. Catherine Ivy is the founder and president of the Ivy … [Continue Reading]

Valley algae company develops beauty products

Heliae, a Gilbert-based algae technology company, and The Clarecastle Group announced today that they have entered into a strategic partnership to bring novel algae-based products to the health and beauty industry. The partnership pairs a leader in algae science and production technology with a seasoned consortium of personal care and … [Continue Reading]

Ivy Foundation Renews Support for TGen Program

The Arizona-based Ben & Catherine Ivy Foundation will fund a second year of the Ivy Neurological Science Internship Program at the Translational Genomics Research Institute (TGen). The internship program offers hands-on biomedical research experience for high school, undergraduate and aspiring medical school students pursuing careers in brain tumor research, neuroscience … [Continue Reading]

BioAccel Challenges Entrepreneurs to Solve Healthcare Problems

BioAccel, a 501(c)3 non-profit and Arizona’s premier resource for healthcare innovation, is announcing the BioAccel Solutions Challenge to solve medical and health delivery problems in Arizona, stimulate new company formation and increase investment in the industry. BioAccel will publicly release a vetted list of key healthcare problems, or “needs,” identified … [Continue Reading]

TGen scientist launches innovative online research project

A scientific researcher at Phoenix-based Translational Genomics Research Institute (TGen) has launched a first-of-its-kind online memory test to help better understand human cognition and how it might relate to Alzheimer’s disease and other brain disorders. Dubbed “MindCrowd”, the study seeks to attract 1 million individuals, aged 18 to 80, willing … [Continue Reading]

Foundation donates $500,000 for TGen research

The Seena Magowitz Foundation has donated $500,000 from two charity golf tournaments dedicated to supporting pancreatic cancer research at the Translational Genomics Research Institute (TGen). Past donations from the Seena Magowitz Foundation have helped fund significant scientific research that is making a difference in the lives of pancreatic cancer patients … [Continue Reading]

Scottsdale Healthcare, John C. Lincoln form affiliation

Scottsdale Healthcare and John C. Lincoln Health Network have endorsed a letter of intent to form a system-wide affiliation to better meet the healthcare needs and thus improve the health of the communities they serve. The nonbinding agreement between the two non-profit organizations allows both to pursue an exclusive negotiation … [Continue Reading]

Guayule could drive Arizona’s economy

It’s common knowledge that America’s largest import is oil, but do you know what’s second? Hint: it’s a commodity used for tires, hoses and thousands of household products. The United States imports 100% of it’s natural rubber from the Hevea tree grown in nations like Indonesia, Thailand and Vietnam. Once … [Continue Reading]

TGen-Scottsdale Healthcare battle tumor growth

The safety and preliminary efficacy of a new class of tumor fighting drugs were reported by Scottsdale Healthcare’s Virginia G. Piper Cancer Center Clinical Trials and the Translational Genomics Research Institute (TGen). Early results from the phase I, first in-human study of an RNA interface (RNAi) drug were announced during … [Continue Reading]

Medical miracle girl raises funds for TGen

Shelby Valint, the 12-year-old Phoenix girl whose sequenced genome led her from a wheelchair to walking, is raising funds for the non-profit Translational Genomics Research Institute (TGen). The “Shelby Valint Inspiration Fundraiser” will generate needed research dollars for TGen’s Center for Rare Childhood Disorders (C4RCD). It was research through this … [Continue Reading]

FDA approved thyroid cancer drug tested by TGen

The FDA has approved a thyroid cancer drug successfully tested at Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and the Translational Genomics Research Institute (TGen). The U.S. Food and Drug Administration approved cabozantinib for the treatment of progressive, metastatic medullary thyroid cancer (MTC), a rare … [Continue Reading]